key: cord-0777686-cagl36nw
authors: Liu, Nanyang; Yang, Di; Zhang, Tingting; Sun, Jiahui; Fu, Jianhua; Li, Hao
title: Systematic review and meta-analysis of olfactory and gustatory dysfunction in coronavirus disease 2019
date: 2022-02-05
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2022.02.004
sha: 5d6fbcd4d4bdf4dc48b73c9f967eb256fefbb40b
doc_id: 777686
cord_uid: cagl36nw

Background Chemosensory disorders associated with coronavirus disease 2019 (COVID-19) have been widely mentioned during the pandemic. We performed a meta-analysis to assess the risk factors for olfactory and gustatory dysfunction in patients with COVID-19. Methods Three databases (PubMed, Embase, and Cochrane Library) were searched for studies published between December 1st, 2019 to August 31st, 2021. Select random effects model or fixed effects model to pool data based on heterogeneity. The results were reported as odds ratios or standardized mean differences and the corresponding 95% confidence intervals. Heterogeneity was reported as I 2. Results Twenty-six studies with a total of 13813 patients were included. The pooled data indicated that sex (OR, 1.47; 95% CI, 0.93-2.31), age (SMD, -5.80; 95% CI, −13.35-1.75), smoking (OR, 2.04; 95% CI, 0.72-5.79), and comorbidity (OR, 1.21; 95% CI, 0.58-2.53) of COVID-19 patients had no effect on gustatory dysfunction. Olfactory dysfunction was more likely to occur in elderly patients with COVID-19 (SMD, -5.22; 95% CI, −8.28- −2.16). And COVID-19 patients with nasal congestion (OR, 3.41;95%CI, 2.30-5.06) and rhinorrhea (OR, 2.35; 95%CI, 1.60-3.45) are more prone to olfactory dysfunction. Conclusion These findings emphasize that elderly COVID-19 patients are more likely to suffer from olfactory dysfunction. Symptoms of nasal congestion and rhinorrhea may affect the recognition of olfactory dysfunction.

Coronavirus disease 2019 , which started at the end of 2019 , is still prevalent worldwide. It has caused more than 200 million infections and 4.3 million deaths, with infection and death numbers continuing to be updated.

People infected with the virus usually develop non-specific symptoms in the prodromal stage of the disease, in which fever, cough, dyspnea, muscle pain and fatigue are the most common symptoms (Huang et al., 2020; Wang et al., 2020) . In the early stages of the outbreak, the world's attention focused on infected cases and people exposed to them. Due to the shortage of test kits, asymptomatic carriers were not tested even in developed countries with good health systems. With the improvement of global detection capabilities, asymptomatic carriers were finally diagnosed, and most of them complained about chemosensory disorders, such as changes in olfactory and gustatory function. (Desiato et al., 2021; Aziz et al., 2021) .

Self-reported chemosensory changes can predict whether a person will be tested positive for SARS-CoV-2. A recent observational study involving more than 2 million participants showed that loss of smell and taste was more predictive than all other symptoms, including fatigue, fever, or cough. However, most of these studies lack objective evaluation methods, increasing the possibility that chemical sensory disorders are more common than currently recognized.

Recent meta-analyses and systematic reviews have reported the prevalence of gustatory and olfactory dysfunction. However, the data vary widely: the incidence of olfactory disorders is between 3% and 98%, and that of gustatory disorders is between 6% and 93% (Tong et al., 2020; Agyeman et al., 2020) . This difference may be related to age, sex, disease severity, and race. The selection of participants may also be responsible for the difference, as some data come from outpatient departments and some from inpatient departments. Although multiple reviews have summarized and analyzed numerous original studies, the effects of age, sex, disease severity, geographic region, and race on COVID-19-related gustatory and olfactory dysfunction are still unclear. Additionally, confirmed cases are usually accompanied by nasal congestion and rhinorrhea, which may affect olfactory function. Therefore, we conducted a systematic review and meta-analysis based on the existing evidence to comprehensively understand the role of the above factors in COVID-19-related gustatory and olfactory dysfunction.

Meta-analyses (PRISMA) reporting guideline and the Meta-analysis of Observational Studies in Epidemiology (MOOSE) reporting guideline (Moher et al., 2009; Stroup et al., 2000) . This study was registered on PROSPERO (CRD42021253869) but the protocol was not prepared.

We systematically searched the PubMed, Embase, and Cochrane databases, from December 1, 2019, to August 31, 2021, to obtain any designed observational studies (cohort, case-control, or cross-sectional) that reported COVID-19 patients with olfactory and gustatory dysfunction. Table 1 in the Supplement provides the detailed query strategy. Two researchers independently screened all the titles and abstracts identified from the search and resolved differences through discussion. The references of relevant studies were cross-checked to find other studies that were not found by the electronic search.

Articles that meet the following criteria were included: (1) observational studies recording data on olfactory and gustatory dysfunction in COVID-19 patients; (2) studies reporting COVID-19 patients with and without olfactory and gustatory dysfunction; We excluded (1) animal studies and (2) brief reports, case reports, letter to editor, reviews, abstracts, and studies that are not available in full text.

Two researchers independently extracted data using a predesigned data extraction 5 table and resolved any disagreements through discussion. The extracted information included study characteristics (eg, publication year, country of origin, study period, study design, and follow-up time, funding sources), participant characteristics (eg, sample size, age, and sex), selection of cases and controls. For each study that reported risk factor data, we obtained the risk ratio (RR) or odds ratio (OR) and the corresponding 95% CI or the number of participants. For cohort and case-control studies, we assessed the risk of bias using the Newcastle-Ottawa Scale and judged studies with scores greater than 6 to have a lower overall risk of bias (Stang, 2010) .

Cross-sectional studies were evaluated using the 11-item checklist recommended by the Agency for Healthcare Research and Quality (AHRQ) (Jue et al., 2019) .

We define dysgeusia, ageusia, taste disorders, taste loss, hypogeusia, change in taste, taste loss, and taste disorder as gustatory dysfunction, while hyposmia, anosmia, smell impairment, small loss, and olfactory disorder are defined as olfactory dysfunction. We pooled data using a random or fixed effect model based on the degree of heterogeneity and reported results using odds ratio (OR) estimates with corresponding 95% confidence interval (CI). Heterogeneity was classified as moderate (I 2 = 25%-50%), substantial (I 2 = 50%-75%) or considerable (I 2 ≥ 75%). We also conducted a sensitivity analysis based on the results. We performed a predefined subgroup analysis based on race (Caucasian and Asian) to assess the potential source of heterogeneity. If the number of included studies was sufficient, the possibility of publication bias was assessed. Variables were compared using the χ 2 test. All tests were two-tailed, and a P value less than 0.05 was considered statistically significant.

A total of 2235 articles were screened, scrutinized 109 full-text articles, and ultimately 26 studies met the inclusion criteria for meta-analysis ( Figure 1 ). Those studies documented patients with and without olfactory and gustatory dysfunction(Le Sanli et al., 2021; Rojas-Lechuga et al., 2021; Sayın et al., 2021; Dev et al., 2021; Sheng et al., 2021; Elibol and Baran, 2021; Samimi et al., 2021; Sahoo et al., 2021; Singer-Cornelius et al., 2021; Porta-Etessam et al., 2021; Gupta et al., 2021; Soh et al., 2021; Tabari et al., 2021; Jain et al., 2021; Lee et al., 2021; Cheng et al., 2021; Ahn and Min, 2021; Klopfenstein et al., 2020; Lv et al., 2020; Jalessi et al., 2020; Petrocelli et al., 2020; Prajapati et al., 2020; Shah et al., 2020; Altundag et al., 2020; Tham et al., 2020) .The 83 excluded articles and the reasons for exclusion are 6 provided in Table 2 in the Supplement.

Detailed information on the included studies is provided in Table 1 . Most of these studies had a retrospective design and involved single-center cohorts. Among the 26 studies, 14 included patients of Asian descent, while the others included patients of European descent. The case group reported olfactory and/or gustatory dysfunction, while the control group did not report complaints in this regard. The quality of the study was moderate quality, with an average score of 6.2 (1.70). All COVID-19 case was confirmed by reverse transcription-polymerase chain reaction and olfactory and gustatory dysfunction were confirmed by self-reporting or testing.

Previous studies have emphasized the contribution of age, sex, and race to olfactory and gustatory dysfunction, but the results are inconsistent. Here, we investigated the role of these risk factors in 26 studies. The results suggested that sex (OR, 1.47; 95% CI, 0.93-2.31), age (SMD, -5.80; 95% CI, −13.35-1.75), smoking (OR, 2.04; 95% CI, 0.72-5.79), and comorbidities (OR, 1.21; 95% CI, 0.58-2.53) had no effect on the occurrence of gustatory dysfunction (Figure 2 ).

The pooled results emphasize that sex (OR, 0.86; 95% CI, 0.62-1.19), smoking (OR, 0.99; 95% CI, 0.78-1.25), and comorbidities (OR, 0.83; 95% CI, 0.61-1.11) have no effect on olfactory dysfunction (Figure 3 ). However, we found age contributed to olfactory dysfunction (SMD, -5.22; 95%CI, −8.28-−2.16) (Figure 4) , as older COVID-19 patients were more likely to develop olfactory dysfunction. Interestingly, nasal congestion (OR, 3.41; 95%CI, 2.30-5.06; P<0.00) and rhinorrhea (OR, 2.35; 95%CI, 1.60-3.45; P<0.00) were more common in patients with olfactory dysfunction than in COVID-19 patients without olfactory dysfunction ( Figure 5 ), possible reasons for olfactory function effects.

Previous studies suggested that COVID-19-related gustatory and olfactory dysfunction may be related to region and race. However, subgroup analysis performed based on race in our research did not indicate any difference between Caucasians and Asians, suggesting that gustatory and olfactory dysfunction in COVID-19 patients may not be related to race (Figure 1 and 2 in the Supplement).

7 Five (50%) pooled effect estimates were found to be significantly heterogeneous.

We performed sensitivity analysis by deleting each study in turn did not result in a substantial change in the results. However, the recalculation of the data set does not reduce the heterogeneity.

Assessment of publication bias is based on sufficient primary study (>9). Neither the visual funnel plot nor the Egger's regression asymmetry test demonstrated statistical publication bias ( Figure 3 in the Supplement).

This systematic review and meta-analysis assessed several related risk factors for gustatory and olfactory dysfunction in COVID-19 patients. The findings indicated that sex, age , smoking , and comorbidity of COVID-19 patients had no effect on gustatory dysfunction. Elderly patients with COVID-19 were more likely to develop olfactory dysfunction. More importantly, the olfactory dysfunction may be related to symptoms of rhinorrhea and nasal congestion. No evidence was found for the effect of racial factors on gustatory and olfactory dysfunction.

There have been multiple reviews investigating gustatory and olfactory dysfunction following COVID-19 infection. O Our work shows that gustatory and olfactory dysfunction do not seem to be related to race, sex, smoking or comorbidities, a finding that is inconsistent with a previous meta-analysis .

Interestingly, olfactory dysfunction is more likely to be caused by nasal congestion and rhinorrhea, although some studies have found that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could damage the olfactory nerve.

The exact pathogenesis of the loss of olfaction and taste caused by COVID-19 is still unclear, but one possible explanation is that virus affect the central nervous system and damage the nasal epithelium . Studies have shown that SARS-CoV-2 may infect the human central nervous system through the nose near the olfactory epithelium and may be neuroinvasive to humans (Chen and Zheng, 2020) . SARS-CoV-2 enters the central nervous system through the olfactory nerve or the peripheral trigeminal nerve. Therefore, COVID-19 can damage the trigeminal nerve and olfactory nerve, causing olfactory and taste disorders. Another explanation may be that SARS-CoV-2 infection reduces the reflex sensitivity of sensory neurons. Furthermore, during the ongoing pandemic, chemicals and disinfectants have been widely used and may cause olfactory and taste disorders 8 (Keyhan et al., 2020) . Despite the above-mentioned evidence, whether SARS-Cov-2 enters the brain through the olfactory nerve and affects brain function is still inconclusive. According to our data, COVID-19-related olfactory dysfunction may be related to nasal symptoms, such as nasal congestion and rhinorrhea.

Nevertheless, COVID-19-related gustatory and olfactory dysfunction may not cause permanent damage because they can spontaneously return to normal in a few weeks after recovery. However, to avoid the long-term existence of gustatory and olfactory dysfunction, timely remedial strategies are necessary. A study found that a combination of short-term oral corticosteroids and olfactory training may help COVID-19 patients with persistent olfactory disorders (Le . Another study used nasal steroids to reduce the severity and duration of olfactory disorders . Similarly, Varia et al (Vaira et al., 2021) found that drug management, including steroids, maybe a potential strategy for alleviating COVID-19-related gustatory and olfactory dysfunction.

This study has some limitations that need to be addressed. First of all, different biases should be considered in observational studies. We combined the results of different types of studies, potentially leading to considerable heterogeneity. Most studies are retrospective, and recall bias may affect the results. Second, since most studies have inconsistent descriptions of olfactory and gustatory dysfunction, we have redefined the data set, which may lead to biased results. Third, some of the included studies reported very limited case data, thus limiting our analysis. Fourth, of the 58 studies included, 28 reported gustatory and olfactory dysfunction based on patients' subjective reports. Due to data limitations, we did not conduct an independent analysis of subjective complaints and objective tests.

Our systematic review and meta-analysis have several advantages. To date, this is the largest review of gustatory and olfactory dysfunction in COVID-19 patients. These data allowed us to study risk differences based on study design and regions. In particular, for patients with different severity of the disease, we further explored their gustatory and olfactory dysfunction. The second advantage is that we have also studied the risk factor data in detail. This allowed us to add several new risk factors for gustatory and olfactory dysfunction that have not been reported in the literature. In addition, our systematic review and meta-analysis included an extensive and comprehensive literature search and an overview of all data, making our results more 9 reliable.

This meta-analysis emphasize that elderly COVID-19 patients are more likely to suffer from olfactory dysfunction and it may recover in a short time when the symptoms of nasal congestion and rhinorrhea disappear.

Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine (No: ZYYCXTD-C-202007).

The authors have no relevant interests to declare.

This study did not require ethical approval because the meta-analysis was based on published research and the original data are anonymous.

s

The authors have no relevant interests to declare. 

Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis

Prevalence of olfactory or gustatory dysfunction in coronavirus disease patients: An analysis based on Korean nationwide claims data

The temporal course of COVID-19 anosmia and relation to other clinical symptoms

The Association of "Loss of Smell" to COVID-19: A Systematic Review and Meta-Analysis

Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection

Understand variability of COVID-19 through population and tissue variations in expression of SARS-CoV-2 host genes

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Younger adults with mild-to-moderate COVID-19 exhibited more prevalent olfactory dysfunction in Taiwan

The Prevalence of Olfactory Dysfunction in the General Population: A Systematic Review and Meta-analysis

COVID-19 with and without anosmia or dysgeusia: A case-control study

The relation between serum D-dimer, ferritin and vitamin D levels, and dysgeusia symptoms, in patients with coronavirus disease 2019

Olfactory and Gustatory Dysfunction in COVID-19 Patients from Northern India: A Cross-Sectional Observational Study

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Is there a correlation between viral load and olfactory & taste dysfunction in COVID-19 patients?

Frequency and outcome of olfactory impairment and sinonasal involvement in hospitalized patients with COVID-19

Developing and Testing the Agency for Healthcare Research and Quality's National Guideline Clearinghouse Extent of Adherence to Trustworthy Standards (NEATS) Instrument

Dysosmia and dysgeusia due to the 2019 Novel Coronavirus; a hypothesis that needs further investigation

New loss of smell and taste: Uncommon symptoms in COVID-19 patients on Nord Franche-Comte cluster, France

Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell

Psychophysical evaluation of chemosensory functions 5 weeks after olfactory loss due to COVID-19: a prospective cohort study on 72 patients

Comparative Study of Chemosensory Dysfunction in COVID-19 in 2 Geographically Distinct Regions

Prevalence and recovery time of olfactory and gustatory dysfunction in hospitalized patients with COVID-19 in Wuhan

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Remote psychophysical evaluation of olfactory and gustatory functions in early-stage coronavirus disease 2019 patients: the Bologna experience of 300 cases

COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry. Infection

Association of subjective olfactory dysfunction and 12-item odor identification testing in ambulatory COVID-19 patients

Chemosensory dysfunction in COVID-19 out-patients

Evolution of olfactory and gustatory dysfunctions in COVID-19 patients in India

The coronavirus disease 2019: the prevalence, prognosis, and recovery from olfactory dysfunction (OD)

Relationship between disease severity and serum IL-6 levels in COVID-19 anosmia

Taste and Smell Impairment in Critically Ill Patients With COVID-19: An Intensive Care Unit Study

Evaluation of Olfactory Acuity in Patients with Coronavirus Disease 2019 (COVID-19)

Dysosmia and dysgeusia in patients with COVID-19 in northern Taiwan

Objective gustatory and olfactory dysfunction in COVID-19 patients: a prospective cross-sectional study

The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients

Prevalence of olfactory and taste dysfunction in COVID-19 patients: a community care facility study

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group

Olfactory Dysfunction is Associated with More Severe Clinical Course in COVID-19

Olfactory taste disorder as a presenting symptom of COVID-19: a large single-center Singapore study

The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis

Efficacy of corticosteroid therapy in the treatment of longlasting olfactory disorders in COVID-19 patients

Prevalence of Chemosensory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis Reveals Significant Ethnic Differences

Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan